AHA 2020: Transgender people have unaddressed heart disease risks
A retrospective study of transgender people using gender-affirming hormone therapy (GAHT) found...
AHA 2020
Latest
ACR 2020
ACR 2020: Selective tyrosine kinase-2 inhibition: a promising new treatment option for psoriatic arthritis
The orally available, selective tyrosine kinase-2 inhibitor deucravacitinib met the primary and all secondary endpoints and improved quality of life in a randomized, double-blind, placebo-controlled phase 2 trial that included...
AAP 2020
AAP: Racial Disparity Observed in Child Abuse Reporting
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
ESMO
Amivantamab-Lazertinib Combo for Resistant EGFR-positive NSCLC
At the European Society for Medical Oncology (ESMO) Virtual Congress 2020 , lead study investigator Prof. Byoung Chul Cho (Yonsei Cancer Centre, Yonsei University College of Medicine in Seoul, South Korea) presented the interim...
MSVirtual2020: ACTRIMS-ECTRIMS
MS Virtual 2020: ECTRIMS-ACTRIMS eBook
ECTRIMS MS 2020v1.indd Featuring…. MS Relapses: In the Past? Ofatumumab Steps Closer...